Innovative Technology Correlia Biosystems' development of microscale tools and the launch of their ELISA platform demonstrate their focus on creating advanced, sample-efficient biological analysis solutions, which could appeal to research institutions seeking cutting-edge lab equipment.
Rapid Market Entry The company's recent ELISA platform launch signals their ability to quickly respond to niche market needs, presenting opportunities for partners looking to incorporate nimble biotech solutions into their workflows.
Growing Funding With nearly 10 million dollars in funding and a revenue range between 1 million and 10 million dollars, Correlia Biosystems is positioned for expansion, potentially increasing the demand for their innovative microlab and biomolecular analysis tools.
Targeted Customer Base Operating in the biotechnology research sector with small team size, Correlia's personalized and scalable platform is well-suited for research laboratories and biotech startups aiming to enhance molecular interaction measurements with minimal sample volumes.
Strategic Partnerships The company's focus on developing customizable tools leveraging cloud and modern tech stacks opens opportunities for collaborations with tech-focused biotech firms and cloud service providers aimed at advancing molecular research technologies.
$1B$10B
$1B$10B
$10B
$10B
$1B$10B
$1B$10B
$10B
$10B
$1B$10B
$1B$10BCorrelia Biosystems uses 8 technology products and services including MySQL, Shopify, Microsoft Excel, and more. Explore Correlia Biosystems's tech stack below.
| Correlia Biosystems Email Formats | Percentage |
| FLast@correliabio.com | 50% |
| First.Last@correliabio.com | 29% |
| First@correliabio.com | 21% |
Biotechnology ResearchCalifornia, United States2-10 Employees
Correlia Biosystems develops innovative microscale tools that accelerate the rate of molecular interactions for rapid measurements of biomolecules. The customizable PIXI platform opens up new biological questions for interrogation from less than two microliters of sample, with rapid results that allow for dynamic monitoring of protein expression profiles.
Company Overview
Funding & FinancialsCorrelia Biosystems has raised a total of $9.6M of funding over 10 rounds. Their latest funding round was raised on Oct 16, 2020 in the amount of $9.6M.
Correlia Biosystems's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsCorrelia Biosystems has raised a total of $9.6M of funding over 10 rounds. Their latest funding round was raised on Oct 16, 2020 in the amount of $9.6M.
Correlia Biosystems's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com